@article{article, title  = {{The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://eprints.whiterose.ac.uk/176339/ }},

 year = {{2021}},

 month = {{7}},

 author = {{Coen O and Corrie P and Marshall H and Plummer R and Ottensmeier C and Hook J and Bell S and Sagoo GS and Meads D and Bestall J and Velikova G et al}},

 doi = {{10.1186/s12885-021-08509-w}},

 volume = {{21}},

 journal = {{BMC Cancer}},

 issue = {{1}},

 note = {{Accessed on 2024/09/19}}}